109 related articles for article (PubMed ID: 31147194)
21. Cardiac Resynchronization Therapy: US Trends and Disparities in Utilization and Outcomes.
Sridhar AR; Yarlagadda V; Parasa S; Reddy YM; Patel D; Lakkireddy D; Wilkoff BL; Dawn B
Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e003108. PubMed ID: 26921376
[TBL] [Abstract][Full Text] [Related]
22. Impact of quadripolar LV leads on heart failure hospitalization rates among patients implanted with CRT-D: data from the Israeli ICD Registry.
Leshem E; Suleiman M; Laish-Farkash A; Haim M; Geist M; Luria D; Glikson M; Goldenberg I; Michowitz Y;
J Interv Card Electrophysiol; 2018 Jan; 51(1):5-12. PubMed ID: 29274032
[TBL] [Abstract][Full Text] [Related]
23. Cardiac venous injuries: Procedural profiles and outcomes during left ventricular lead placement for cardiac resynchronization therapy.
Chahine J; Baranowski B; Tarakji K; Gad MM; Saliba W; Rickard J; Cantillon DJ; Diab M; Kanj M; Callahan T; Dresing T; Bhargava M; Chung M; Niebauer MJ; Varma N; Tchou P; Wilkoff BL; Wazni O; Hussein AA
Heart Rhythm; 2020 Aug; 17(8):1298-1303. PubMed ID: 32205298
[TBL] [Abstract][Full Text] [Related]
24. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
[TBL] [Abstract][Full Text] [Related]
25. Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
Martens P; Verbrugge FH; Nijst P; Dupont M; Nuyens D; Herendael HV; Rivero-Ayerza M; Tang WH; Mullens W
Heart; 2017 Dec; 103(24):1977-1984. PubMed ID: 28716973
[TBL] [Abstract][Full Text] [Related]
26. Cardiac resynchronization therapy-defibrillator improves long-term survival compared with cardiac resynchronization therapy-pacemaker in patients with a class IA indication for cardiac resynchronization therapy: data from the Contak Italian Registry.
Morani G; Gasparini M; Zanon F; Casali E; Spotti A; Reggiani A; Bertaglia E; Solimene F; Molon G; Accogli M; Tommasi C; Paoletti Perini A; Ciardiello C; Padeletti L
Europace; 2013 Sep; 15(9):1273-9. PubMed ID: 23439866
[TBL] [Abstract][Full Text] [Related]
27. The prognostic benefit of cardiac resynchronization therapy is greater in concordant vs. discordant left bundle branch block in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
Padeletti L; Aimo A; Vishenvsky B; Schwartz A; McNitt S; Wang PJ; Moss AJ; Emdin M; Zareba W
Europace; 2018 May; 20(5):794-800. PubMed ID: 28398490
[TBL] [Abstract][Full Text] [Related]
28. Does Age Influence Cardiac Resynchronization Therapy Use and Outcome?
Heidenreich PA; Tsai V; Bao H; Curtis J; Goldstein M; Curtis L; Hernandez A; Peterson P; Turakhia MP; Masoudi FA
JACC Heart Fail; 2015 Jun; 3(6):497-504. PubMed ID: 25982109
[TBL] [Abstract][Full Text] [Related]
29. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry.
Zusterzeel R; Spatz ES; Curtis JP; Sanders WE; Selzman KA; Piña IL; Bao H; Ponirakis A; Varosy PD; Masoudi FA; Caños DA; Strauss DG
Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821
[TBL] [Abstract][Full Text] [Related]
30. Cause-of-death analysis in patients with cardiac resynchronization therapy with or without a defibrillator: a systematic review and proportional meta-analysis.
Barra S; Providência R; Duehmke R; Boveda S; Begley D; Grace A; Narayanan K; Tang A; Marijon E; Agarwal S
Europace; 2018 Mar; 20(3):481-491. PubMed ID: 28666319
[TBL] [Abstract][Full Text] [Related]
31. Incidence, predictors, and procedural results of upgrade to resynchronization therapy: the RAFT upgrade substudy.
Essebag V; Joza J; Birnie DH; Sapp JL; Sterns LD; Philippon F; Yee R; Crystal E; Kus T; Rinne C; Healey JS; Sami M; Thibault B; Exner DV; Coutu B; Simpson CS; Wulffhart Z; Yetisir E; Wells G; Tang AS
Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):152-8. PubMed ID: 25417892
[TBL] [Abstract][Full Text] [Related]
32. Sustained clinical benefit of cardiac resynchronization therapy in non-LBBB patients with prolonged PR-interval: MADIT-CRT long-term follow-up.
Stockburger M; Moss AJ; Klein HU; Zareba W; Goldenberg I; Biton Y; McNitt S; Kutyifa V
Clin Res Cardiol; 2016 Nov; 105(11):944-952. PubMed ID: 27318807
[TBL] [Abstract][Full Text] [Related]
33. Left Ventricular Lead Location and Long-Term Outcomes in Cardiac Resynchronization Therapy Patients.
Kutyifa V; Kosztin A; Klein HU; Biton Y; Nagy VK; Solomon SD; McNitt S; Zareba W; Goldenberg I; Roka A; Moss AJ; Merkely B; Singh JP
JACC Clin Electrophysiol; 2018 Nov; 4(11):1410-1420. PubMed ID: 30466845
[TBL] [Abstract][Full Text] [Related]
34. Cardiac Resynchronization Defibrillator Therapy for Nonspecific Intraventricular Conduction Delay Versus Right Bundle Branch Block.
Kawata H; Bao H; Curtis JP; Minges KE; Mitiku T; Birgersdotter-Green U; Feld GK; Hsu JC
J Am Coll Cardiol; 2019 Jun; 73(24):3082-3099. PubMed ID: 31221257
[TBL] [Abstract][Full Text] [Related]
35. Adding the implantable cardioverter-defibrillator to cardiac resynchronization therapy is associated with improved long-term survival in ischaemic, but not in non-ischaemic cardiomyopathy.
Witt CT; Kronborg MB; Nohr EA; Mortensen PT; Gerdes C; Jensen HK; Nielsen JC
Europace; 2016 Mar; 18(3):413-9. PubMed ID: 26378089
[TBL] [Abstract][Full Text] [Related]
36. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.
Killu AM; Park JY; Sara JD; Hodge DO; Gersh BJ; Nishimura RA; Asirvatham SJ; McLeod CJ
Europace; 2018 Jan; 20(1):82-88. PubMed ID: 29315424
[TBL] [Abstract][Full Text] [Related]
37. Time-dependent risk reduction of ventricular tachyarrhythmias in cardiac resynchronization therapy patients: a MADIT-RIT sub-study.
Stockburger M; Moss AJ; Olshansky B; Klein H; McNitt S; Schuger C; Daubert JP; Goldenberg I; Ruwald AC; Merkely B; Zareba W; Kutyifa V
Europace; 2015 Jul; 17(7):1085-91. PubMed ID: 25745075
[TBL] [Abstract][Full Text] [Related]
38. Sex-Related Procedural Aspects and Complications in CRT Survey II: A Multicenter European Experience in 11,088 Patients.
Auricchio A; Gasparini M; Linde C; Dobreanu D; Cano Ó; Sterlinski M; Bogale N; Stellbrink C; Refaat MM; Blomström-Lundqvist C; Lober C; Dickstein K; Normand C
JACC Clin Electrophysiol; 2019 Sep; 5(9):1048-1058. PubMed ID: 31537334
[TBL] [Abstract][Full Text] [Related]
39. Evaluation, Management, and Outcomes of Patients Poorly Responsive to Cardiac Resynchronization Device Therapy.
Varma N; Boehmer J; Bhargava K; Yoo D; Leonelli F; Costanzo M; Saxena A; Sun L; Gold MR; Singh J; Gill J; Auricchio A
J Am Coll Cardiol; 2019 Nov; 74(21):2588-2603. PubMed ID: 31748196
[TBL] [Abstract][Full Text] [Related]
40. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT.
Brenyo A; Rao M; Barsheshet A; Cannom D; Quesada A; McNitt S; Huang DT; Moss AJ; Zareba W
J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
